FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/091002 [Registered on: 16/07/2025] Trial Registered Prospectively
Last Modified On: 14/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Screening 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Study Of Kulattha Seed Powder In increased cholesterol levels to prevent cardiovascular diseases 
Scientific Title of Study   Evaluation and Clinical Study Of Kulattha Dolichos biflorus linn on Medovriddhi wsr Hyperlipidemia 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Parul Saini 
Designation  PG Scholar 
Affiliation  Sri Ganganagar College of Ayurvedic Science and Hospital 
Address  Department Of Dravyaguna Vigyan Sri Ganganagar College of Ayurvedic Science and Hospital Tantia University Riico Sri Ganganagar 335002
Department Of Dravyaguna Vigyan Sri Ganganagar College of Ayurvedic Science and Hospital Tantia University Riico Sri Ganganagar 335002
Ganganagar
RAJASTHAN
335002
India 
Phone  8266936367  
Fax  2494125  
Email  sainiparul888@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Omprakash Sharma 
Designation  HOD Dravyaguna Vigyan 
Affiliation  Sri Ganganagar College of Ayurvedic Science and Hospital 
Address  Department of Dravyagun Vigyan Sri Ganganagar College of Ayurvedic Science and Hospital Tantia University Riico Sri Ganganagar 335002
Department Of Dravyagun Vigyan Sri Ganganagar College of Ayurvedic Science and Hospital Tantia University Riico Sri Ganganagar 335002
Ganganagar
RAJASTHAN
335002
India 
Phone  9414248057  
Fax  2494125  
Email  dr.opsarswat@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Parul Saini 
Designation  PG Scholar 
Affiliation  Sri Ganganagar College of Ayurvedic Science and Hospital 
Address  Department of Dravyaguna Vigyan Sri Ganganagar College of Ayurvedic Science and Hospital Tantia University Riico Sri Ganganagar 335002
Department Of Dravyaguna Vigyan Sri Ganganagar College of Ayurvedic Science and Hospital Tantia University Riico Sri Ganganagar 335002
Ganganagar
RAJASTHAN
335002
India 
Phone  8266936367  
Fax  2494125  
Email  sainiparul888@gmail.com  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  Dr Parul Saini 
Address  Sri Ganganagar College of Ayurvedic Science and Hospital Tantia University Riico Sri Ganganagar 335002 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Parul Saini  Sriganganagar College Of Ayurvedic Science And Hospital  Department Of Dravyaguna Vigyan
Ganganagar
RAJASTHAN 
8266936367

sainiparul888@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committe  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E660||Obesity due to excess calories. Ayurveda Condition: MEDOVRUDDHIH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugOther than Classical(1) Medicine Name: Kulattha beej churna, Reference: NA, Route: Oral, Dosage Form: Churna/ Powder, Dose: 01(g), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 02 Months, anupAna/sahapAna: Yes(details: Ushna Jal), Additional Information: NA
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  all subjects with visible sign and symptoms of hyperlipidemia between the age of 30 to 60 years of age  
 
ExclusionCriteria 
Details  Patient With Underlaying Morbid Disease 
 
Method of Generating Random Sequence   Adaptive randomization, such as minimization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Lipid Profile Result Correction And To Prevent Cardiovascular Disease  60 Days  
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="2"
Days="15" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This Trial Will Conclude The Hypolipidemic Activity Of Kulattha Described In Ayurveda And It Will Evaluate The Efficacy Of Hypolipidemic Action Of Kulattha On Internal Use  
Close